文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

新型分子宿主反应检测诊断ICU急性呼吸衰竭住院患者感染的有效性验证

Validation of a Novel Molecular Host Response Assay to Diagnose Infection in Hospitalized Patients Admitted to the ICU With Acute Respiratory Failure.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论在因急性呼吸衰竭入ICU且感染病因不确定的住院患者中,SeptiCyte LAB的诊断价值有限,与C反应蛋白的判别能力相似。

这项嵌套队列研究在荷兰两个三级混合ICU进行,纳入2011至2013年因急性呼吸衰竭需机械通气入ICU的住院患者,排除已有明确感染诊断或明显非感染性插管原因者。入ICU时采血行SeptiCyte LAB检测,结果分为4个概率等级,与事后严格定义评估的感染可能性比较。467例中373例(80%)因疑似感染接受治疗,感染可能性被判定为排除、不确定、确认者分别为135例(29%)、135例(29%)、197例(42%)。检测结果与感染可能性相关(Spearman rho 0.332;p < 0.001),排除不确定病例后,概率等级2、3、4的阳性预测值分别为29%、54%、76%,等级1的阴性预测值为76%,SeptiCyte LAB与C反应蛋白的诊断判别能力相似(p = 0.919)。作者结论认为在该人群中SeptiCyte LAB的诊断价值有限。

要点

  • 在因急性呼吸衰竭入ICU的住院患者中,SeptiCyte LAB结果与感染可能性相关(Spearman rho 0.332;p < 0.001),但判别能力有限。
  • 排除不确定病例后,概率等级2、3、4的阳性预测值分别为29%、54%、76%,等级1的阴性预测值为76%。
  • SeptiCyte LAB与C反应蛋白的诊断判别能力相似(p = 0.919)。
  • 467例中373例(80%)入ICU时因疑似感染接受治疗,但事后评估确认感染仅197例(42%)。
  • 作者结论:在感染病因不确定的急性呼吸衰竭住院患者中,SeptiCyte LAB的诊断价值有限。

适用人群与场景

  • 2011至2013年入住荷兰两个三级混合ICU、入ICU时因急性呼吸衰竭需要机械通气的住院患者。
  • 排除已有明确感染诊断或存在明显非感染性插管原因的患者。

研究设计与关键结果

  • 研究类型为嵌套队列研究,纳入467例患者,来自荷兰两个三级混合ICU。
  • 入ICU时采血行SeptiCyte LAB检测,结果分为4个概率等级(等级越高感染概率越高),与事后严格定义评估的感染可能性比较。
  • 467例中373例(80%)入ICU时因疑似感染接受治疗;感染可能性判定为排除135例(29%)、不确定135例(29%)、确认197例(42%)。
  • 检测结果与感染可能性相关(Spearman rho 0.332;p < 0.001)。
  • 排除不确定病例后,概率等级2、3、4的阳性预测值分别为29%、54%、76%;等级1的阴性预测值为76%。
  • SeptiCyte LAB与C反应蛋白的诊断判别能力相似(p = 0.919)。

证据类型、等级与局限

  • 证据类型:嵌套队列研究。
  • 作者结论:在该人群中SeptiCyte LAB的诊断价值有限。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在因急性呼吸衰竭入ICU且感染病因不确定的住院患者中,SeptiCyte LAB的诊断价值有限。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Discrimination between infectious and noninfectious causes of acute respiratory failure is difficult in patients admitted to the ICU after a period of hospitalization. Using a novel biomarker test (SeptiCyte LAB), we aimed to distinguish between infection and inflammation in this population.

DESIGN: Nested cohort study.

SETTING: Two tertiary mixed ICUs in the Netherlands.

PATIENTS: Hospitalized patients with acute respiratory failure requiring mechanical ventilation upon ICU admission from 2011 to 2013. Patients having an established infection diagnosis or an evidently noninfectious reason for intubation were excluded.

INTERVENTIONS: None.

MEASUREMENT AND MAIN RESULTS: Blood samples were collected upon ICU admission. Test results were categorized into four probability bands (higher bands indicating higher infection probability) and compared with the infection plausibility as rated by post hoc assessment using strict definitions. Of 467 included patients, 373 (80%) were treated for a suspected infection at admission. Infection plausibility was classified as ruled out, undetermined, or confirmed in 135 (29%), 135 (29%), and 197 (42%) patients, respectively. Test results correlated with infection plausibility (Spearman's rho 0.332; p < 0.001). After exclusion of undetermined cases, positive predictive values were 29%, 54%, and 76% for probability bands 2, 3, and 4, respectively, whereas the negative predictive value for band 1 was 76%. Diagnostic discrimination of SeptiCyte LAB and C-reactive protein was similar (p = 0.919).

CONCLUSIONS: Among hospitalized patients admitted to the ICU with clinical uncertainty regarding the etiology of acute respiratory failure, the diagnostic value of SeptiCyte LAB was limited.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Koster-Brouwer ME, Verboom DM, Scicluna BP, et al. Validation of a Novel Molecular Host Response Assay to Diagnose Infection in Hospitalized Patients Admitted to the ICU With Acute Respiratory Failure. Crit Care Med. 2018. PMID: 29474322. doi:10.1097/CCM.0000000000002735

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。